Univ. Prof. Dr. med. Dietrich Rothenbacher

  • Forschung

    Interessenschwerpunkte

    Epidemiologie von chronischen Erkrankungen, speziell kardiovaskulären und metabolischen Erkrankungen, Infektionserkrankungen, Klinische Epidemiologie, Biomarkerforschung, Pharmakoepidemiologie und Meta-Analysen.

  • Lehre

    Lehre

    • Humanmedizin: Q1 Epidemiologie (Seminar und Vorlesung)

    • Molekularmedizin: Widening the Scientific Horizon (Seminar und Vorlesung, Lehrbeauftragter)

    • Master Online Advanced Oncology (Lehrbeauftragter)

    • International Summer School of Epidemiology (Organisator)
  • Publikationen

    Orginalarbeiten

    313. Matsushita K, Ballew SH, Coresh J, Arima H, Ärnlöv J, Cirillo M, Ebert N, Hiramoto JS, Kimm H, Shlipak MG, Visseren FLJ, Gansevoort RT, Kovesdy CP, Shalev V, Woodward M, Kronenberg F; Chronic Kidney Disease Prognosis Consortium*. Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. 2017 Jul 14. pii: S2213-8587(17)30183-3. doi:10.1016/S2213-8587(17)30183-3. [Epub ahead of print] *Rothenbacher D collaborator

    312. Christiansen H, Brandt S, Walter V, Wabitsch M, Rothenbacher D, Brenner H, Schimmelmann BO, Hirsch O. Prediction of BMI at age 11 in a longitudinal sample of the Ulm Birth Cohort Study. PLoS One 2017 (in press).

    311. Zewinger S, Kleber ME, Tragante V, […]Rothenbacher D,[…], März W, Speer T. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. The Lancet Diabetes & Endocrinology 2017; 5:534-543.

    310. GBD 2015 Healthcare Access and Quality Collaborators*. Healthcare Access and Quality Index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: a novel analysis from the Global Burden of Disease Study 2015. Lancet. 2017 May 18. pii: S0140-6736(17)30818-8. doi: 10.1016/S0140-6736(17)30818-8. [Epub ahead of print] *Rothenbacher D collaborator

    309. Florian MC, Klenk J, Marka G, Soller K, Kiryakos H, Peter R, Herbolsheimer F, Rothenbacher D, Denkinger M, Geiger H. Expression and activity of the small RhoGTPase Cdc42 in blood cells of older adults are associated with age and cardiovascular disease. J Gerontol A Biol Sci Med Sci. 2017 May 12. doi: 10.1093/gerona/glx091. [Epub ahead of print]

    308. Giné-Garriga M, Coll-Planas L, Guerra M, Domingo À, Roqué M, Caserotti P, Denkinger M, Rothenbacher D, Tully MA, Kee F, McIntosh E, Martín-Borràs C, Oviedo GR, Jerez-Roig J, Santiago M,  Sansano O, Varela G, Skjødt M, Wirth K, Dallmeier D, Klenk J, Wilson JJ, Blackburn NE, Deidda M, Lefebvre G, González D, Salvà A. The SITLESS project: Exercise Referral Schemes enhanced by Self-Management Strategies to battle sedentary behaviour in older adults: study protocol for a randomized controlled trial. Trials 2017; 18:221.

    307. Braig S, Urschitz MS, Rothenbacher D, Genuneit J. Changes in children’s sleep domains between 2 and 3 years of life – the Ulm SPATZ Health Study. Sleep Medicine 2017; 36:18-22.

    306. Nagel G, Peter RS, Rosenbohm A, Koenig W, Dupuis L, Rothenbacher D, Ludolph AC and the ALS Registry Study Group. Adipokines, C-reactive protein and Amyotrophic Lateral Sclerosis – results from a population- based ALS registry in Germany. Scientific Reports 2017; 7:4374.

    305. Tam ZY, Pin Ng S, Tan LQ, Lin CH, Rothenbacher D, Klenk J, Boehm BO. Metabolite profiling in identifying metabolic biomarkers in older people with late-onset type 2 diabetes mellitus. Scientific Reports 2017; 7:4392.

    304. Ziemssen T, Rothenbacher D, Kuhle J, Berger T.Real-World Evidenz. Vorteile und Limitationen am Beispiel der Multiplen Sklerose. Der Neurologe 2017 (in press)

    303. Logan CA, Brandt S, Wabitsch M, Brenner H, Wiens F, Stahl B, Marosvölgyi T, Decsi T, Rothenbacher D, Genuneit J. New approach shows no association between maternal milk fatty acid composition and childhood wheeze or asthma. Allergy 2017 Mar 17. doi: 10.1111/all.13161. [Epub ahead of print].

    302. Elgizouli M, Logan C, Grychtol R, Rothenbacher D, Nieters A, Heinzmann A. Reduced PRF1 enhancer methylation in children with a history of severe RSV bronchiolitis in infancy: an association study. BMC Pediatrics 2017; 17:65.

    301. Rosenbohm A, Peter RS, Erhardt S, Lulé D, Rothenbacher D, Ludolph AC, Nagel G, and the ALS registry Study Group. Epidemiology of Amyotrophic Lateral Sclerosis in Southern Germany. Journal of Neurology 2017; 264: 749-757.

    300. Pfetsch V, Sanin V, Jaensch A, Dallmeier D, Mons U, Brenner H, Koenig W, Rothenbacher D. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-year Follow-up of the KAROLA Study. Cardiovascular Drugs and Therapy 2017; 31:167-177.

    299. Logan CA, Bornemann R, Koenig W, Reister F, Walter V, Fantuzzi G, Weyermann M, Brenner H, Genuneit J, Rothenbacher D. Gestational weight gain and fetal-maternal adiponectin, leptin, and CRP: results of two birth cohorts studies. Scientific Reports 2017; 7:41847.

    298. Wirth K, Klenk J, Brefka S, Faehling F, Roqué i Figuls M, Tully MA, Rothenbacher D, Denkinger M, Stubbs B, SITLESS consortium.. Biomarkers associated with sedentary behaviour in older adults: a systematic review. Ageing Research Reviews 2017; 35:87-111.

    297. Global Burden of Disease 2013 GFR Collaborators*. Global cardiovascular and renal outcomes of reduced GFR. Journal of the American Society of Nephrology 2017; 28:2167-79. *Rothenbacher D coauthor

    296. Laszlo R, Kunz K, Dallmeier D, Klenk J, Denkinger M, Koenig W, Rothenbacher D, Steinacker JM, for the ActiFE Study group. Accuracy of ECG indices for diagnosis of left ventricular hypertrophy in people > 65 years: Results from the ActiFE study" and your careful consideration of the Referees' recommendations. Aging Clinical and Experimental Research 2016;  Nov 9. [Epub ahead of print]

    295. Braisch U, Hay B, Muche R, Rothenbacher D, Landwehrmeyer GB, Long JD, Orth D, and REGISTRY Investigators of the European Huntington’s Disease Network and COHORT Investigators of the Huntington Study Group. Identification of extreme motor phenotypes in Huntington’s disease. Neuropsychiatric Genetics 2017; 174:283-294.

    294. Braig S, Weiss JM, Stalder T, Kirschbaum C, Rothenbacher D, Genuneit J. Maternal prenatal stress and child atopic dermatitis up to age 2 years: the Ulm SPATZ Health Study. Pediatric Allergy and Immunology 2017; 28:144-151.

    293. Rapp K; Kampe K; Roigk P; Kircheisen H; Becker C; Lindlbauer I; König HH; Rothenbacher D; Büchele G. The osteoporotic fracture prevention program in rural areas (OFRA). A cluster-randomized health care fund driven intervention in a routine health care setting. BMC Musculoskeletal Disorders 2016; 17:458.

    292. GBD 2015 Risk Factors Collaborators*. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015.  Lancet 2016; 388:1659-1724. *Rothenbacher D collaborator

    291. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators*. Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388:1545-1602. *Rothenbacher D collaborator

    290. GBD 2015 SDG Collaborators*. Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. Lancet 2016; 388:1813-1850 *Rothenbacher D collaborator

    289. Logan C, Rothenbacher D, Genuneit J. Postpartum Smoking Relapse and Breastfeeding: Defining the Window of Opportunity for Intervention. Nicotine & Tobacco Research 2017; 19:367-72. (Epub 2016; Sep 9. pii: ntw224.)

    288. Bluhmki T, Peter R, Rapp K, König HH, Becker C, Lindlbauer Y, Rothenbacher D, Beyersmann J, Büchele G.. Understanding mortality of femoral fractures following low-impact trauma in persons with and without care need. Journal of the American Medical Directors Association 2017; 18:221-226.

    287. Breitling L, Mons U, Hahmann H, Koenig W, Rothenbacher D, Brenner H. The Longer, the Better? An empirical study of the extent and mechanisms of attenuating biomarker associations in cardiovascular patient cohorts. Clinical Chemistry 2017; 63:673-82.

    286. Büchele G, Becker C, Cameron I, Auer R, Rothenbacher D, König HH; Rapp K. Fracture risk in people with developmental disabilities: results of a large claims data analysis. Osteoporosis International 2017; 28:369-375

    285. Laszlo R, Baumann T, Konz H, Dallmeier D, Klenk J, Denkinger M, Koenig W, Rothenbacher D, Steinacker JM  for the ActiFe Study. Echocardiographic B-mode evaluation of the right heart in older people: the ActiFE Study. Archives of Gerontology and Geriatrics 2016; 67: 145-152.

    284. GBD Mortality and Causes of Death Collaborators*. Global, regional, and national life expectancy, all-cause and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388:1459-1544. Rothenbacher D collaborator.

    283. Palumbo P, Klenk J, Cattelani L, Bandinelli L, Ferrucci L, Rapp K, Chiari L, Rothenbacher D. Predictive performance of a fall risk assessment tool for community-dwelling older people (FRAT-up) in four European cohorts. Journal of the American Medical Directors Association 2016; 17:1106-1113.

    282. Jansen H, Koenig W, Jaensch A, Mons U, Breitling LP, Scharnagl H, Stojakovic T, Schunkert H, Brenner H, Rothenbacher D. Prognostic Utility of Galectin-3 for Recurrent Cardiovascular Events During Long-term Follow-up in Patients with Stable Coronary Heart Disease. Results of the KAROLA Study. Clinical Chemistry 2016; 62:1372-1379.

    281. Laszlo R, Baumann T, Konz H, Dallmeier D, Klenk J, Denkinger M, Koenig W, Rothenbacher D, Steinacker JM, for the ActiFe Study. Right ventricular function assessed by Tissue Doppler echocardiography in older subjects without evidence for structural cardiac disease. Aging Clinical and Experimental Research 2017; 29:557-562 (epub 2016; May 31)

    280. Dallmeier D, Brenner H, Mons U, Rottbauer W, Koenig W, Rothenbacher D. Growth differentiation factor 15, its 12-months relative change, and risk of cardiovascular events and total mortality in patients with stable coronary heart disease: 10-year follow-up of the KAROLA Study. Clinical Chemistry 2016; 62: 982-992.

    279. Klenk J, Dallmeier D, Denkinger MD, Rapp K, Koenig W, Rothenbacher D, and the ActiFE Study Group. Objectively measured walking duration and sedentary behaviour and four-year mortality in older people. PLoS One 2016; 11:e0153779.

    278. Benzinger P, Becker C, Todd C, Bleibler F, Rothenbacher D, König HH, Rapp K. The impact of preventive measures on the burden of femoral fractures – a modelling approach to estimating the impact of fall prevention exercises and oral bisphosphonate treatment for the years 2014 and 2025. BMC Geriatrics 2016; 16:75.

    277. Peter RS, Brehme T, Völzke H, Muche R, Rothenbacher D, Büchele G. Epidemiologic Research Topics in Germany: A Keyword Network Analysis of 2014 DGEpi Conference Presentations. European Journal of Epidemiology 2016; 31:635-638.

    276. Büchele G, Rapp K, Hamburg, Sieber C, Jaensch A, Rothenbacher D, Becker C, Benzinger P. Risk of hospital admission due to traumatic brain injury in older persons with and without severe functional limitations. Journal of the American Medical Directors Association 2016; 17:609-12.

    275. Logan C, Zittel T, Striebel S, Reister F, Brenner H, Rothenbacher D, Genuneit J. The influence of changing societal and lifestyle factors on breastfeeding patterns over time. Pediatrics 2016; 137: e20154473.

    274. Logan CA, Thiel L, Bornemann R, Koenig  W, Reister F, Brenner H, Rothenbacher D, Genuneit J. Delivery mode, duration of labor, and cord blood adiponectin, leptin, and C-reactive protein: Results of the population-based Ulm Birth Cohort Studies. PLoS One 2016; 11:e0149918.

    273. Global Burden of Disease Pediatrics Collaboration*. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013: Findings From the Global Burden of Disease 2013 Study. JAMA Pediatrics 2016; 170:267-87. *Rothenbacher D collaborator

    272. Klenk J, Büchele G, Lindemann U, Kaufmann S,  Peter R, , Laszlo R, Kobe S, Rothenbacher D. Concurrent validity of activPAL and activPAL3 accelerometers in older adults. Journal of Aging and Physical Activity 2016; 24:444-450

    271. Meyer ML, Jaensch A, Mons U, Breitling LP, Hahmann H, Koenig W, Brenner H, Rothenbacher D. Atrial fibrillation and long-term prognosis of patients with stable coronary heart disease: relevance of routine electrocardiogram. International Journal of Cardiology 2016: 203:1014-1015.

    270. Kovesdy CP, Coresh J, Ballew SH, Woodward M, Levin A, Naimark D, Nally J, Rothenbacher D, Stengel B, Iseki K, Matsushita K, Levey AS, for the CKD Prognosis Consortium. Past decline versus current eGFR and subsequent ESRD risk. Journal of the American Society of Nephrology 2016; 27:2447-55.

    269. Naimark DM, Grams ME, Matsushita K, Black C, Drion I, Fox CS, Inker L, Ishani A, Jee SH, Kitamura A, Lea J, Nally J, Peralta C, Rothenbacher D, Ryu S, Tonelli M, Yatsuya H, Coresh J, Gansevoort RT, Warnock D, Woodward M, de Jong PE for the CKD Prognosis Consortium. Past decline versus current eGFR and subsequent mortality risk. Journal of the American Society of Nephrology 2016; 27:2447-55.

    268. Brück K,  Stel VS, Gambaro G, Hallan S, Völzke H, Ärnlöv J, Kastarinen M, Guessous I, Vinhas J, Stengel B, Brenner H, Chudek J, Romundstad S, Tomson C, Gonzalez AO, Bello AK, Ferrieres J, Palmieri L, Browne G, Capuano V, Van Biesen W, Zoccali C, Gansevoort R, Navis G, Rothenbacher D, Ferraro PM, Nitsch D, Wanner C, Jager KJ. Chronic kidney disease prevalence varies across European general population. Journal of the American Society of Nephrology 2016; 27:2135-2147.

    267. Imhof A, Koenig W, Jaensch A, Mons U, Brenner H, Rothenbacher D. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease. Atherosclerosis 2015; 243:414-420.

    266. Braig S, Grabher F, Pilz C, Reister F, Stalder T, Kirschbaum C, Rothenbacher D, Genuneit J. The association of hair cortisol with self-reported chronic psychosocial stress and symptoms of anxiety and depression in women shortly after delivery. Paediatric and Perinatal Epidemiology 2016; 30:97-104 (Epub 2015 Nov 3)

    265. White IR, Rapsomaniki E; Emerging Risk Factors Collaboration*. Covariate-adjusted measures of discrimination for survival data. Biometrical Journal 2015;57(4):592-613. *Rothenbacher D collaborator

    264. GBD 2013 DALYs and HALE Collaborators*. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet 2015; 386;2145-91. *Rothenbacher D collaborator

    263. Boehme MW, Buechele G, Frankenhauser-Mannuss J, Mueller J, Lump D, Boehm BO, Rothenbacher D. Prevalence, incidence and concomitant co-morbidities of type 2 diabetes mellitus in South Western Germany - a retrospective cohort and case control study in claims data of a large statutory health insurance. BMC Public Health 2015; 15:855.

    262. Mayer B, Ring C, Muche R, Rothenbacher D, Schmidt-Straßburger U. Creating a blended learning module in an online master study programme in oncology. Education in Health (Abingdon) 2015; 28:101-5.

    261. Rothenbacher D, Dallmeier  D, Mons U, Rosamond W, Koenig W, Brenner H. Sexual Activity Patterns before Myocardial Infarction and Risk for Subsequent Cardiovascular Adverse Events. Journal of the American College of Cardiology 2015; 66:1516-7.

    260. Brück K, Jager KJ, Dounousi E, Kainz A, Nitsch D, Ärnlöv J, Rothenbacher D, Browne G, Capuano V, Ferraro PM, Ferrieres J, Gambaro G, Guessous I, Hallan S, Kastarinen M, Navis G, Gonzalez AO, Palmieri L, Romundstad S, Spoto B, Stengel B, Tomson C, Tripepi G, Völzke H, Wiȩcek A, Gansevoort R, Schöttker B, Wanner C, Vinhas J, Zoccali C, Van Biesen W, Stel VS; European CKD Burden Consortium. Methodology used in studies reporting chronic kidney disease prevalence: a systematic literature review. Nephrology Dialysis Transplantation 2015 Aug;30 (suppl 4):iv6-iv16. doi: 10.1093/ndt/gfv131.

    259. Dallmeier D, Klenk J, Peter RS, Denkinger M, Peter R, Rapp K, Koenig W, Rothenbacher D, for the ActiFE Study Group. A prospective assessment of cardiac biomarkers for hemodynamic  stress and necrosis and the risk of falls among older people: the ActiFE Study. European Journal of Epidemiology 2016; 31:427-435. (epub 2015).

    258. Rapp K, Magaziner J, Becker C, Benzinger P, Bleibler F, König HH, Jaensch A, Rothenbacher D, Büchele G. Risk of nursing home admission after femoral fracture compared to stroke, myocardial infarction and pneumonia. Journal of the American Medical Directors Association 2015; 16:715.e7-715.e12.

    257. Glaser N, Deckert A, Phiri S, Rothenbacher D, Neuhann S. Comparison of various equations for estimating GFR in Malawi: How to determine renal function in resource limited settings? PLoS One 2015 ;10:e0130453

    256. Ntekim A, Campbell O, Rothenbacher D. Optimal management of cervical cancer in HIV positive patients: A systematic review. Cancer Medicine 2015; 4:1381-93.

    255. Matsushita K, Coresh J, Sang Y, Chalmers J, Fox C, Guallar E, Jafar T, Jassal SK, Landman GWD, Muntner P, Roderick P, Sairenchi T, Schöttker B, Shankar A, Shlipak M, Tonelli M, Townend J, van Zuilen A, Yamagishi K, Yamashita K, Gansevoort R, Sarnak M, Warnock DG, Woodward M, Ärnlöv J, for the CKD Prognosis Consortium*. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes - a collaborative meta-analysis of individual participant data. Lancet Diabetes & Endocrinology 2015; 3:514–25. *Rothenbacher D collaborator

    254. Klenk J, Kerse N, Rapp K, Nikolaus T, Becker C, Rothenbacher D, Peter R, Denkinger M, and the ActiFE Study Group. Physical activity and different concepts of fall risk estimation in older people - results of the ActiFE-Ulm study. PLoS One 2015; 10:e0129098.

    253. GBD 2013 Disease and Injury Incidence and Prevalence Collaborators*.Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 386:743-800. *Rothenbacher D collaborator

    252. Rothenbacher D, Capkun G, Uenal H, Tumani H, Geissbühler Y, Tilson H. New opportunities of real world data from clinical routine settings in life cycle-management of drugs: example of an integrative approach in multiple sclerosis. Current Medical Research & Opinion 2015; 31:953-65.

    251. Brandt S, Moß A, Koenig W, Florath  I, Rothenbacher D, Brenner H, Wabitsch M. Intrafamilial associations of cardiometabolic risk factors – results of the Ulm Birth Cohort Study. Atherosclerosis 2015; 240: 174-183.

    250. Nagel G, Herbolsheimer F, Riepe M, Nikolaus T, Denkinger M, Peter R, Weinmayr G, Rothenbacher D, Koenig W, Ludolph AC, von Arnim CAF, and the ActiFE Study group. Serum vitamin D concentrations and cognitive function in a population-based study among older adults in South Germany. Journal of Alzheimer Disease 2015; 45:1119-26.

    249. Dallmeier D, Pencina MJ, Rajman I, Koenig W, Rothenbacher D, Brenner H. Serial measurements of N-Terminal Pro-Brain Natriuretic Peptide in patients with coronary heart disease. PLoS One 2015; 10:e0117143.

    248. Klenk J, Rapp K, Denkinger M; Nagel G; Nikolaus N; Peter R; Boehm BO, Koenig W, Rothenbacher D, and the ActiFE Study Group. Objectively measured physical activity and vitamin D status in older people from Germany. Journal of Epidemiology & Community Health 2015; 69:388-92.

    247. Emrich IE, Pickering J, Schöttker B, Lennartz CS, Rogacev KS, Brenner H, Rothenbacher D, Holleczek B, Saum KU, Fliser D, Heine GH. Comparison of the performance of two GFR Estimating Equations using creatinine and cystatin C to predict adverse outcomes in elderly individuals. American Journal of Kidney Diseases 2015; 65:636-8.

    246. Braig S, Grabher F, Ntomchukwu C, Reister F, Stalder T, Kirschbaum C, Genuneit J, Rothenbacher D. Determinants of maternal hair cortisol concentrations at delivery reflecting the last trimester of pregnancy. Psychoneuroendocrinology 2015; 52:289-96.

    245. GBD Mortality and Causes of Death Collaborators*. Global, regional, and national levels of age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385:117-71. *Rothenbacher D collaborator

    244. Elgizouli M, Logan C, Nieters A, Brenner H, Rothenbacher D. Cord blood PRF1 methylation patterns and risk of lower respiratory tract infections in infants: findings from the Ulm Birth Cohort. Medicine 2015; 94:e332.

    243. Dallmeier D, Denkinger M, Peter R, Rapp K, Jaffe AS, Koenig W, Rothenbacher D for the ActiFE Study Group. Sex-specific associations of established and emerging cardiac biomarkers with all-cause mortality in older adults: the ActiFE study. Clinical Chemistry 2015: 61:389-99.

    242. Vart P, Bakker SJL, Schöttker B, de Zeeuw D, Rothenbacher D, Brenner H, Lambers Heerspink HJ, Saum KU, Reijneveld SA, Bültmann U, Koenig W, Gansevoort RT. Relevance of Correction for Drift and Day-To-Day Variation in Cystatin C Measurement: A post-hoc analysis of the PREVEND cohort, with independent replication in the ESTHER cohort. Clinical Chemistry and Laboratory Medicine 2015; 53:1381-1390.

    241. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative*. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies. International Journal of Surgery 2014; 12:1495-9. *Rothenbacher D contributor

    240. Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative*. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration. International Journal of Surgery 2014; 12:1500-24. *Rothenbacher D contributor

    239. Braig S, Brandt S, Wabitsch M, Florath I, Brenner H, Rothenbacher D, Genuneit J. Age-specific influence of wheezing phenotypes on preadolescent and adolescent health-related quality of life. Pediatric Allergy and Immunology 2014; 25:781-787.

    238. Coresh J, Chowdhury T, Matsushita K, Sang Y, Ballew SH, Appel LJ, Arima H, Chadban SJ, Cirillo M, Djurdjev O, Green JA, Heine GH, Inker LA, Irie F, Ishani A, Ix JH, Kovesdy CP, Marks A, Ohkubo T, Shalev V, Shankar A, Wen CP, de Jong PE, Iseki K, Stengel B, Gansevoort RT, Levey AS; for the CKD Prognosis Consortium*. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. Journal of the American Medical Association (JAMA) 2014; 311:2518-31. * Rothenbacher D collaborator

    237. The Emerging Risk Factors Collaboration*. Glycated Hemoglobin Measurement and Prediction of Cardiovascular Disease; The Emerging Risk Factors Collaboration. Journal of the American Medical Association (JAMA) 2014; 311:1225-1233. *Rothenbacher D collaborator

    236. Karakas M, Jaensch A, Breitling LP, Brenner H, Koenig W, Rothenbacher D. Prognostic value of Mid-regional Pro A-type Natriuretic Peptide and N-terminal Pro B-type Natriuretic Peptide in Patients with Stable Coronary Heart Disease Followed over 8 Years. Clinical Chemistry 2014; 60:1441-9.

    235. Rothenbacher D, Jaensch A, Mons U, Hahmann H, Becker T, Koenig W, Brenner H. Prognostic Value of One-Year Course of Symptoms of Anxiety and Depression in Patients with Coronary Heart Disease: Role of Physical Activity and Unmet Medical Need. European Journal of Preventive Cardiology 2015; 22:1129-38. (2014 epub).

    234. Łuczyńska A , Logan C, Nieters A, Elgizouli M, Schöttker B, Brenner H, Rothenbacher D. Cord blood 25(OH)D levels and the subsequent risk of lower respiratory tract infections in early childhood: the Ulm Birth Cohort. European Journal of Epidemiology 2014; 29:585-94.

    233. Florath I, Brandt S, Weck MW, Rothenbacher D, Wabitsch M, Brenner H. Evidence of inappropriate cardiovascular risk assessment in middle-age women based on recommended cut-points for waist circumference. Nutrition, Metabolism and Cardiovascular Diseases 2014: 24:1112-9.

    232. Pennells L, Kaptoge S, White IR, Thompson SG, Wood AM; Emerging Risk Factors Collaboration*. Assessing risk prediction models using individual participant data from multiple studies. American Journal of Epidemiology 2014; 179:621-632. * Rothenbacher D collaborator

    231. Uenal H, Rosenbohm A, Kufeldt J, Weydt P, Goder K, Ludolph A, Rothenbacher D, Nagel G, and the ALS registry Study Group. Incidence and geographical variation of amyotrophic lateral sclerosis (ALS) in Southern Germany – Completeness of the ALS registry Swabia. PLoS One 2014 9:e93932.

    230. Wen CP, Matsushita K, Coresh J, Iseki K, Islam M, Katz R, McClellan W, Peralta CA, Wang HY, de Zeeuw D, Astor BC, Gansevoort RS, Levey A, Levin A for the Chronic Kidney Disease Prognosis Consortium*. Relative risks of chronic kidney disease for mortality and end-stage renal disease across races are similar. Kidney International 2014 advance online publication 12 February 2014; doi: 10.1038/ki.2013.553 * Rothenbacher D collaborator

    229. Brandt S, Moß A, Lennerz B, Koenig W. Weck M, Weyermann M, Rothenbacher D, Brenner H. Wabitsch M. Plasma insulin levels and BMI trajectories in childhood – Results of the Ulm Birth Cohort Study.  Pediatric Diabetes 2014; 15: 453-63.

    228. Rothenbacher D, Klenk J, Denkinger D, Herbolsheimer F, Nikolaus T, Peter P, Boehm BO, Rapp K, Dallmeier D, Koenig W for the ActiFE Study Group. Prospective Evaluation of Renal Function, Serum Vitamin D Level, and Risk of Fall and Fracture in Community Dwelling Elderly Subjects. Osteoporosis International 2014; 25:923-32.

    227. Singh GM, Danaei G, Farzadfar F, Stevens GA, Woodward M, Wormser D, Kaptoge S, Whitlock G, Qiao Q, Lewington S, Di Angelantonio E, Vander Hoorn S, Lawes CM, Ali MK, Mozaffarian D, Ezzati M; Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group; Asia-Pacific Cohort Studies Collaboration (APCSC); Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe (DECODE); Emerging Risk Factor Collaboration (ERFC); Prospective Studies Collaboration (PSC)*. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis. PLoS One 2013;8:e65174. * Rothenbacher D collaborator

    226. Genuneit J, Braig S, Brandt S , Wabitsch M, Florath I, Brenner H, Rothenbacher D. Infant atopic eczema and subsequent attention-deficit/hyperactivity disorder –a prospective birth cohort study. Pediatric Allergy and Immunology 2014; 25:51-6.

    225. Mons U, Raum E, Krämer HU, Rüter G, Rothenbacher D, Rosemann T, Szecsenyi J, Brenner H. Effectiveness of a supportive telephone counseling intervention in type 2 diabetes patients: randomized controlled study. PLoS One 2013; 8: e77954e77954.

    224. Rothenbacher D, Hoffmann MM, Breitling LP, Rajman I,Koenig W, Brenner H. Cytochrome P450 2C19*2 polymorphism in patients with stable coronary heart disease and risk for secondary cardiovascular disease events. Results of a long-term follow-up study in routine clinical care. BMC cardiovascular disorders 2013; 13:61.

    223. Schöttker B, Brenner H, Koenig W, Müller H, Rothenbacher D. Prognostic association of HbA1c and fasting plasma glucose with reduced kidney function in subjects with and without diabetes mellitus. Results from a population-based cohort study from Germany. Preventive Medicine 2013; 57:596-600.

    222. Holmes MV, Simon T, Exeter H, […], Rothenbacher D, […], Talmud PJ. Secretory Phospholipase A2-IIA and Cardiovascular Disease: a Mendelian randomization study. Journal of the American College of Cardiology 2013; 62:1966-76.

    221. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne K, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT, for the CKD Prognosis Consortium. Cystatin C versus creatinine in determining risk based kidney function. New England Journal of Medicine 2013; 369:932-43.

    220. Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL,Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS–Cancer Research UK GWAS–ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study Collaborators; PRACTICAL (Prostate Cancer Association Group to Investigate Cancer-Associated Alterations in the Genome) Consortium, Kote-Jarai Z, Easton DF. Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nature Genetics 2013; 45:385-91.

    219. Nitsch D, Grams M, Sang Y, Black C, Cirillo M, Djurdjev O, Iseki K, Jassal SK, Kimm H, Kronenberg F, Oien CM, Levey AS, Levin A, Woodward M, Hemmelgarn BR; Chronic Kidney Disease Prognosis Consortium*. Associations of estimated glomerular filtration rate and albuminuria with mortality and renal failure by sex: a meta-analysis. BMJ 2013;346: f324. doi: 10.1136/bmj.f324.* Rothenbacher D collaborator

    218. Zhang Y, Weck MN, Schöttker B, Rothenbacher D, Brenner H. Gastric parietal cell antibodies, Helicobacter pylori infection, and chronic atrophic gastritis: Evidence from a large population-based study in Germany. Cancer Epidemiology, Biomarker & Prevention 2013; 22: 821-6.

    217. Klenk J, Rapp K, Denkinger M, Nagel G, Nikolaus T, Peter R, Koenig W, Boehm BO, Rothenbacher D. Seasonality of vitamin D status in older people in Southern Germany: implications for assessment. Age and Ageing 2013; 42:404-8.

    216. Nagel G, Uenal H, Rosenbohm A, Ludolph AC, Rothenbacher D. Implementation of a population-based epidemiological rare disease registry: Study protocol of the amyotrophic lateral sclerosis (ALS) - registry Swabia. BMC Neurology 2013; 13: 22.

    215. Schöttker B, Herder C, Rothenbacher D, Perna L, Müller H,  Brenner H.  Serum 25-hydroxyvitamin D levels and incident diabetes mellitus type 2. A competing risk analysis in a large population-based cohort of older adults. European Journal of Epidemiology 2013; 28:267-75.

    214. Florath I, Kohler M, Weck MN, Brandt S, Rothenbacher D, Schöttker B, Moß A, Gottmann P, Wabitsch M, Brenner H. Association of pre- and postnatal parental smoking with offspring body mass index: 8-year follow-up of a birth cohort. Pediatric Obesity 2014; 9:121-134.

    213. Schöttker B, Herder C, Rothenbacher D, Roden M, Kolb H, Müller H, Brenner H. Proinflammatory cytokines, adiponectin and increased risk of primary cardiovascular events in diabetes patients with or without renal dysfunction: results from the ESTHER study. Diabetes Care 2013; 36:1702-11.

    212. Hallan SI, Matsushita K, Sang Y, Mahmoodi BK, Black C, Ishani A, Kleefstra N, Naimark D, Roderick P, Tonelli M, Wetzels JF, Astor BC, Gansevoort RT, Levin A,Wen CP, Coresh J; Chronic Kidney Disease Prognosis Consortium*. Age and association of kidney measures with mortality and end-stage renal disease. Journal of the American Medical Association (JAMA) 2012; 308:2349-60. .* Rothenbacher D collaborator

    211. Matshushita K et al , and for Chronic Kidney Disease Prognosis Consortium*. Cohort profile: The chronic kidney disease prognosis consortium. International Journal of Epidemiology 2013; 42: 1660-8 [epub 2012]  * Rothenbacher D collaborator

    210. Mahmoodi BK, Matsushita K, Woodward M, Blankestijn PJ, Cirillo M, Ohkubo T, Rossing P, Sarnak MJ, Stengel B, Yamagishi K, Yamashita K, Zhang L, Coresh J, de  Jong PE, Astor BC; Chronic Kidney Disease Prognosis Consortium*. Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without hypertension: a meta-analysis. Lancet 2012; 380:1649-61.* Rothenbacher D collaborator

    209. Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, Giles GG, Severi G, Neal DE, Hamdy FC, Donovan JL, Hunter DJ, Henderson BE, Thun MJ, Gaziano M, Giovannucci EL, Siddiq A, Travis RC, Cox DG, Canzian F, Riboli E, Key TJ, Andriole G, Albanes D, Hayes RB, Schleutker J, Auvinen A, Tammela TL,Weischer M, Stanford JL, Ostrander EA, Cybulski C, Lubinski J, Thibodeau SN, Schaid DJ, Sorensen KD, Batra J, Clements JA, Chambers S, Aitken J, Gardiner RA, Maier C, Vogel W, Dörk T, Brenner H, Habuchi T, Ingles S, John EM, Dickinson JL, Cannon-Albright L, Teixeira MR, Kaneva R, Zhang HW, Lu YJ, Park JY, Cooney KA, Muir KR, Leongamornlert DA, Saunders E, Tymrakiewicz M, Mahmud N, Guy M,Govindasami K, O'Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, MorrisonJ, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English D, Virtamo J, Le Marchand L, Campa D, Kaaks R, Lindstrom S, Diver WR, Gapstur S, Yeager M, Cox A, Stern MC, Corral R, Aly M, Isaacs W, Adolfsson J, Xu J, Zheng SL, Wahlfors T, Taari K, Kujala P, Klarskov P, Nordestgaard BG, Røder MA, Frikke-Schmidt R, Bojesen SE, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Rinckleb A, Luedeke M, Herkommer K, Meyer A, Serth J, Marthick JR, Patterson B, Wokolorczyk D, Spurdle A, Lose F, McDonnell SK, Joshi AD, Shahabi A, Pinto P, Santos J, Ray A, Sellers TA, Lin HY, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; The UK ProtecT Study Collaborators; The Australian Prostate Cancer Bioresource; The PRACTICAL Consortium, Chanock S, Gronberg H, Haiman CA, Kraft P, Easton DF, Eeles RA. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Human Molecular Genetics 2013; 22:408-415. [epub 2012]

    208. Emerging Risk Factors Collaboration*. C-reactive protein, fibrinogen, and cardiovascular disease prediction. New England Journal of Medicine 2012; 376: 1310-20. * Rothenbacher D collaborator

    207. Siegerink B, Maas R, Vossen CY, Schwedhelm E, Koenig W, Böger R, Rothenbacher D, Brenner H, Breitling LP. Asymmetric and symmetric dimethylarginine and risk of secondary cardiovascular disease events and mortality in patients with stable coronary heart disease: the KAROLA follow-up study. Clinical Research in Cardiology 2013: 102:193-202. [epub 2012]

    206. Rothenbacher D, Kleiner A, Koenig W, Primatesta P, Breitling LP, Brenner H. Relationship between inflammatory cytokines and serum uric acid levels with adverse cardiovascular outcomes in patients with stable coronary heart disease during long-term follow-up. PLoS One 2012; 7: e45907.

    205. Schöttker, B, Müller H, Raum E, Rothenbacher D, Brenner H. Fasting plasma glucose and haemoglobin A1c in cardiovascular risk prediction - a sex specific comparison in individuals without diabetes mellitus. Diabetologia 2013; 56:92-100. (epub 2012)

    204. Emerging Risk Factors Collaboration*. Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis. International Journal of Epidemiology 2012; 41: 1419-33. * Rothenbacher D collaborator

    203. Klenk J, Denkinger M, Nikolaus T, Peter R, Rothenbacher D, Koenig W for the ActiFE study group. Association of objectively measured physical activity with established and novel cardiovascular biomarkers in the elderly: Every step counts. Journal of Epidemiology & Community Health 2013; 67:194-197 (epub 2012).

    202. Fox CS, MD, Matsushita K, Woodward M, et al on behalf of the CKD Prognosis Consortium*. Associations of Kidney Disease Measures with Mortality and End-Stage Renal Disease in Individuals With and Without Diabetes: A Meta-analysis. The Lancet 2012; 380:1662-73 * Rothenbacher D collaborator

    201. Krämer HU, Raum E, Rüter G, Schöttker B, Rothenbacher D, Rosemann T, Szecsenyi J Brenner H. Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: Results from the DIANA study. Cardiovascular Diabetology 2012; 11:88.

    200. Koenig W, Breitling LP, Hahmann H, Wüsten B, Brenner H, Rothenbacher D. Cardiac troponin T measured by a high sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-Year follow-up. Clinical Chemistry 2012; 58:1215-24.

    199. Krämer E, Rüter G, Rothenbacher D, Rosemann T, Szecsenyi J, Raum E, Brenner H. Medication non-adherence and poor glycaemic control in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2012; 97:377-84.

    198. Rothenbacher D, Klenk J, Denkinger M, Karakas M, Nikolaus T, Peter R, Koenig W. Prevalence and Determinants of Chronic Kidney Disease in Community-Dwelling Elderly by Various Estimating Equations. BMC Public Health 2012; 12:343.

    197. von Eynatten M, Breitling LP, Roos M, Baumann M, Rothenbacher D, Brenner H. Circulating Adipocyte Fatty Acid-Binding Protein Levels And Cardiovascular Morbidity and Mortality in Patients with Coronary Heart Disease - A 10-year Prospective Study. Ateriosclerosis, Thrombosis and Vascular Biology 2012; 32:2327-35.

    196. Kunihiro Matsushita K, Mahmoodi BK, Woodward M, et al. for the Chronic Kidney Disease Prognosis Consortium*. Comparison of risk prediction using the CKD-EPI equation and the MDRD Study equation for estimated glomerular filtration rate. The Journal of the American Medical Association 2012; 307:1941-51. * Rothenbacher D collaborator

    195. Maatouk I, Wild B, Herzog W, Wesche D, Schellberg D, Raum E, Müller H, Rothenbacher D, Stegmaier C, Brenner H Longitudinal predictors of health-related quality of life in elderly people with hypertension – results of a population-based study. Journal of Hypertension 2012; 30:1364-72.

    194. Krämer H U, Müller H, Stegmaier C, Rothenbacher D, Raum E, Brenner H. Type 2 diabetes mellitus and gender-specific risk for colorectal neoplasia. European Journal of Epidemiology 2012; 27:341-7.

    193. Beyerlein A, Nehring I, Rhezak P, Heinrich J, Müller MJ, Plachta-Danielzik S, Wabitsch M, weck M, Brenner H, Rothenbacher D, von Kries R. Gestational weight gain and body mass index in children: Results from three German cohort studies. PloS ONE 2012; 7:e33205.

    192. Breitling LP, Salzmann K, Rothenbacher D, Burwinkel B, Brenner H. Smoking, F2RL3 methylation and prognosis in stable coronary heart disease. European Heart Journal 2012; 58:1215-24.

    191. Krämer HK, Rüter G, Schöttker B, Rothenbacher D, Rosemann T, Szecsenyi J, Brenner H, Raum E. Gender differences in health care utilization of diabetes patients. American Journal of Managed Care 2012; 18: 362-69.

    190. Rapsomaniki E, White IR, Wood AM, Thompson SG, and the Emerging Risk Factors Collaboration*. A framework for qualifying net benefits of alternative prognostic models. Statistics in Medicine 2012; 31: 114-30. * Rothenbacher D collaborator

    189. Grandi NC, Brenner H, Hahmann H, Wüsten B, März W, Rothenbacher D, Breitling LP. Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart 2012; 98:926-33.

    188. Wild. B, Herzog W, Lechner S, Niehoff D, Brenner H, Müller H, Rothenbacher D, Stegmaier C, Raum E. Gender specific temporal and cross-sectional associations between BMI-class and symptoms of depression in the elderly. Journal of Psychosomatic Research 2012; 72:376-382.

    187. Nagel G, Rosenbohm A, Ünal H, Rothenbacher D, Ludolph AC für die ALS-Register Studiengruppe. Möglichkeiten register-basierter Studien zur Erforschung Seltener Erkrankungen - Beispiel des ersten deutschen bevölkerungsbezogenen Registers für die Amyotrophe Lateralsklerose. Aktuelle Neurologie 2012; 39: 12-7.

    186. Maatouk M, Wild B, Wesche D, Herzog W, Raum E, Müller H, Rothenbacher D, Stegmeier C, Schellberg D, Brenner H. Temporal predictors of health-related quality of life in elderly people with diabetes - results from a German cohort study. PLoS ONE 2012; 7: e31088.

    185. Schöttker B; Herder C, Müller H, Brenner H, Rothenbacher D. Clinical utility of creatinine and cystatin C based definition of renal function for risk prediction of primary cardiovascular events in patients with diabetes. Diabetes Care 2012; 35: 879-86.

    184. Schöttker B, Raum E, Rothenbacher D, Müller H, Brenner H. Prognostic value of fasting plasma glucose and haemoglobin A1c for incident diabetes in a cohort of elderly and implications for screening. European Journal of Epidemiology 2011; 26: 779-87.

    183. Kote-Jarai Z, Olama AA, Giles GG, Severi G, Schleutker J, Weischer M, Campa D, Riboli E, Key T, Gronberg H, Hunter DJ, Kraft P, Thun MJ, Ingles S, Chanock S, Albanes D, Hayes RB, Neal DE, Hamdy FC, Donovan JL, Pharoah P, Schumacher F, Henderson BE, Stanford JL, Ostrander EA, Sorensen KD, Dörk T, Andriole G, Dickinson JL, Cybulski C, Lubinski J, Spurdle A, Clements JA, Chambers S, Aitken J, Gardiner RA, Thibodeau SN, Schaid D, John EM, Maier C, Vogel W, Cooney KA, Park JY, Cannon-Albright L, Brenner H, Habuchi T, Zhang HW, Lu YJ, Kaneva R, Muir K, Benlloch S, Leongamornlert DA, Saunders EJ, Tymrakiewicz M, Mahmud N, Guy M, O'Brien LT, Wilkinson RA, Hall AL, Sawyer EJ, Dadaev T, Morrison J, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As N, Woodhouse CJ, Thompson A, Christmas T, Ogden C, Cooper CS, Lophatonanon A, Southey MC, Hopper JL, English DR, Wahlfors T, Tammela TL, Klarskov P, Nordestgaard BG, Røder MA, Tybjærg-Hansen A, Bojesen SE, Travis R, Canzian F, Kaaks R, Wiklund F, Aly M, Lindstrom S, Diver WR, Gapstur S, Stern MC, Corral R, Virtamo J, Cox A, Haiman CA, Le Marchand L, Fitzgerald L, Kolb S, Kwon EM, Karyadi DM, Orntoft TF, Borre M, Meyer A, Serth J, Yeager M, Berndt SI, Marthick JR, Patterson B, Wokolorczyk D, Batra J, Lose F, McDonnell SK, Joshi AD, Shahabi A, Rinckleb AE, Ray A, Sellers TA, Lin HY, Stephenson RA, Farnham J, Muller H, Rothenbacher D, Tsuchiya N, Narita S, Cao GW, Slavov C, Mitev V; The UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; The UK ProtecT Study Collaborators, The Australian Prostate Cancer BioResource; The PRACTICAL Consortium, Easton DF, Eeles RA. Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nature Genetics 2011; 10: 785-91.

    182. Breitling LP, Koenig W,  Fischer M, Mallat Z, Hengstenberg C, Rothenbacher D, Brenner H. Type II secretory phospholipase A2 and prognosis in patients with stable coronary heart disease: Mendelian randomization study. PLoS ONE 2011; 6:e22318.

    181. Wild B, Herzog W, Schellberg D, Lechner S, Niehoff D, Brenner H, Rothenbacher D, Stegmaier C, Raum E. Association between the prevalence of depression and age in a large representative German sample of people aged 53 to 80 years. International Journal of Geriatric Psychiatry 2012; 27: 375-81 (epub2011 doi: 10.1002/gps.2728).

    180. Breitling LP, Müller H, Dahmen T, Illig T, Rujescu D, Nitz B, Raum E,  Winterer G, Rothenbacher D, Brenner H. Dopamine-related genes and spontaneous smoking cessation in ever-heavy smokers. Pharmacogenomics 2011; 12: 1099-106.

    179. Primatesta P, Plana E, Rothenbacher D. Gout treatment and comorbidities: a retrospective cohort study in a large US managed care population. BMC Musculoskeletal Disorders 2011; 12: 103

    178. Grandi NC; Breitling LP,; Hahmann H, Wüsten B, März W, Rothenbacher D, Brenner H. Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease. Heart 2011; 97: 1215-21.

    177. Breitling LP, Rothenbacher D, Grandi NC, März W, Brenner H. Prognostic usefulness of free fatty acids in patients with stable coronary heart disease. American Journal of Cardiology 2011; 108: 508-13.

    176. Cea-Soriano L, Rothenbacher D, Choi HK, Garcia Rodriguez LA. Contemporary epidemiology of gout in the UK general population. Arthritis Research & Therapy 2011; 13: R39.

    175. Breitling LP, Rothenbacher D, Vossen CY, Hahmann H, Wüsten B, Brenner H. Validated smoking cessation and prognosis in patients with stable coronary heart disease. Journal of the American College of Cardiology 2011; 58: 196-7.

    174. Herder C, Schoettker B, Rothenbacher D, Roden M, Kolb H, Müller H, Brenner H.. Interleukin-6 in the prediction of primary cardiovascular events in diabetes patients: results from the ESTHER study. Atherosclerosis 2011; 216:244-7.

    173. Lattka E, Rzehak P, Szabó É, Jakobik V, Weck M, Weyermann M, Grallert H, Rothenbacher D, Heinrich J, Brenner H, Decsi T, Illig T, Koletzko B. Genetic variants in the FADS gene cluster are associated with arachidonic acid levels of human breast milk at 1.5 and 6 months post partum and influence the course of milk dodecanoic, tetracosenoic and trans-19-octadecenoic acid levels over the duration of lactation. Americal Journal of Clinical Nutrition 2011; 93:382-91.

    172. Rothenbacher D, Primatesta P, Ferreira A, Cea-Soriano L, Garcia Rodriguez LA. Frequency and risk factors of gout flares in a large population-based cohort of incident gout. Rheumatology 2011; 50:973-81.

    171. Emerging Risk Factors Collaboration* Diabetes mellitus, fasting glucose, and risk of cause-specific death. New England Journal of Medicine 2011; 364:829-841. * Rothenbacher D collaborator

    170. Thompson S, Kaptoge S, White I, Wood A, Perry P, Danesh J; Emerging Risk Factors Collaboration*. Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies. International Journal of Epidemiology 2010; 39:1345-59. * Rothenbacher D collaborator

    169. Emerging Risk Factors Collaboration*, Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, Ingelsson E, Lawlor DA, Selvin E, Stampfer M,Stehouwer CD, Lewington S, Pennells L, Thompson A, Sattar N, White IR, Ray KK, Danesh J. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. The Lancet 2010; 375:2215-22. * Rothenbacher D collaborator

    168. Breitling LP, Arndt V, Drath C, Rothenbacher D, Brenner H. Smoking and γ-glutamyltransferase: opposite interactions with alcohol consumption and body mass index. PLoS ONE. 2010; 5: e13116.

    167. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration*, Sarwar N, Sandhu MS, Ricketts SL, Butterworth AS, Di Angelantonio E, Boekholdt SM, Ouwehand W, Watkins H, Samani NJ, Saleheen D, Lawlor D, Reilly MP, Hingorani AD, Talmud PJ, Danesh J. Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. The Lancet 2010; 375: 1634-9. * Rothenbacher D collaborator

    166. Adamu MA, Weck MN, Rothenbacher D, Brenner H. Incidence and risk factors for the development of chronic atrophic gastritis: Five year follow-up of a population based cohort study. International Journal of Cancer 2011; 128:1652-8. [Epub 2010]

    165. Gao L, Weck MN, Rothenbacher D, Brenner H. Body mass index, chronic atrophic gastritis and heartburn: a population-based study among 8936 older adults from Germany. Alimentary Pharmacology & Therapeutics 2010; 32:296-302.

    164. Grandi NC, Breitling LP, Vossen CY, Hahmann H, Wüsten B, März W, Rothenbacher D, Brenner H. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. American Journal of Cardiology 2010; 159:1044-1051.

    163. Duwensee K, Breitling LP, Tancevski I, Rothenbacher D, Demetz E, Ritsch A, Patsch JR, Eller P, Brenner H. Cholesteryl ester transfer protein and prognosis in patients with stable coronary heart disease. European Journal of Clinical Investigation 2010; 40:616-22.

    162. The Chronic Kidney Disease Prognosis Consortium*. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality: a collaborative meta-analysis of general population cohorts. The Lancet 2010; 375:2073-81. * Rothenbacher D collaborator

    161. The Lp-PLA2 Study Collaboration*. Lipoprotein-associated phospholipase A2 and risk of coronary heart disease, stroke and mortality: collaborative analysis of 32 prospective cohorts. The Lancet 2010; 375:1536-44. * Rothenbacher D collaborator

    160. Zhang QL, Brenner H, Koenig W, Rothenbacher D. Prognostic value of chronic kidney disease in patients with coronary heart disease: role of estimating equations. Atherosclerosis 2010; 211:342-7.

    159. Roos M, Eynatten M, Heemann U, Rothenbacher D, Brenner H, Breitling LP. Serum fetuin-A, cardiovascular risk factors and 6-year follow-up in patients with coronary heart disease. American Journal of Cardiology 2010; 105:1666-72.

    158. Breitling LP, Grandi N, Hahmann H, Wüsten B, Rothenbacher D, Brenner H. Gamma-glutamyltransferase and prognosis in patients with stable coronary heart disease followed over 8 years. Atherosclerosis 2010; 210:649-55.

    157. Gao L, Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Alcohol consumption, serum gamma-glutamyltransferase and Helicobacter pylori infection in a population-based study among 9733 older adults. Annals of Epidemiology 2010; 20: 122-8.

    156. Breitling LP, Raum E, Müller H, Rothenbacher D, Brenner H. Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 2009; 49: 802-8.

    155. The Emerging Risk Factor Collaboration*. Major lipids, apolipoproteins, and risk of vacular disease. The Journal of the American Medical Association 2009; 302:1993-2000.* Rothenbacher D collaborator

    154. The Emerging Risk Factor Collaboration*. C-reactive protein concentration and the risk of coronary heart disease, stroke and mortality. Collaborative analysis of data on 160,309 participants from 54 cohorts. The Lancet 2010; 375:132-40. * Rothenbacher D collaborator

    153. Breitling LP, Rothenbacher D, Stegmaier C, Raum E, Brenner H. Older smokers` motivation and attempts to quit smoking. Deutsches Aertzeblatt International 2009; 106:451-55.

    152. Koenig W, Vossen CY, Mallat Z, Brenner H, Benessiano J, Rothenbacher D. Association between type II secretory phospholipase A2 plasma concentrations and activity and cardiovascular events in patients with coronary heart disease. European Heart Journal 2009; 30:2742-2748.

    151. Gao L, Weck MN, Raum E, Stegmaier C, Rothenbacher D, Brenner H. Sibship size, Helicobacter pylori infection and chronic atrophic gastritis: a population-based study among 9444 older adults from Germany. International Journal of Epidemiology 2010; 39: 129-34.

    150. The Emerging Risk Factor Collaboration*. Lipoprotein(a) concentration and the risk of coronary heart disease, stroke and nonvascular mortality. Individual data analysis of 126,634 participants from 36 prospective studies. The Journal of the American Medical Association 2009; 302:412-23. * Rothenbacher D collaborator.

    149. Mobascher A, Rujescu D, Mittelstraß K, Giegling I, Lamina C, Nitz B, Brenner H, Fehr C, Breitling LP, Gallinat J, Rothenbacher D, Raum E, Müller H, Ruppert A, Hartmann AM, Möller HJ, Gal A, Gieger C, Wichmann HE, Illig T, Dahmen N, Winterer G. Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction. Neuropsychiatric Genetics 2010; 153B:684-90 (epub 2009).

    148. Breitling LP, Dahmen N, Illig T, Rujescu D, Nitz B, Raum E, Winterer G, Rothenbacher D, Brenner H. Variants in COMT and spontaneous smoking cessation: retrospective cohort analysis of 925 cessation events. Pharmacogenetics & Genomics 2009; 19:657-9.

    147. Karakas M, Hoffmann M, Vollmert C, Rothenbacher D, Meisinger C, Winkelmann B, Khuseyinova N, Böhm BO, Illig T, März W, Koenig W. Genetic variation in Fcγ receptor IIa and risk of coronary heart disease: negative results from two large independent populations. BMC Medical Genetics 2009, 10:46.

    146. Gao L, Weck MN, Stegmaier C, Rothenbacher D, Brenner H. Alcohol consumption and chronic atrophic gastritis: population-based study among 9444 older adults from Germany. International Journal of Cancer 2009; 125:2918-22.

    145. Szabo E, Boehm G, Beermann C, Weyermann M, Brenner H, Rothenbacher D, Decsi T. Fatty acid profile comparison in human milk sampled from the same mothers at the sixth week and the sixth month of lactation. Journal of Pediatric Gastroenterology & Nutrition 2010; 50:316-20 (epub2009)

    144. Müller H, Raum E, Rothenbacher D, Stegmaier C, Brenner H. Association of diabetes and body mass index with levels of prostate-specific antigen: Implications for correction of prostate-specific antigen cut-off values? Cancer Epidemiology, Biomarker & Prevention 2009; 18:1350-6.

    143. Breitling LP, Dahmen N, Mittelstraß K, Rujescu D, Gallinat J, Fehr C, Giegling I, Lamina C, Illig T, Müller H, Raum E, Rothenbacher D, Wichmann HE, Brenner H, Winterer G. Association study of nicotinic acetylcholine receptor subunit alpha-4 polymorphisms with nicotine dependence in 5500 Germans. Pharmacogenomics Journal 2009; 9:219-24.

    142. Breitling LP, Raum E, Müller H, Rothenbacher D, Brenner H.  Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase. Hepatology 2009; 49: 802-8.

    141. Brenner H, Rothenbacher D, Arndt V. Epidemiology of stomach cancer. Methods in Molecular Biology 2009;472: 467-77.

    140. Zhang QL, Koenig W, Raum E, Stegmaier C, Brenner H, Rothenbacher D. Epidemiology of chronic kidney disease: Results from a population of older adults in Germany. Preventive Medicine 2008; 48: 122-127.

    139. Weyermann M, Rothenbacher D, Brenner H. Acquisition of Helicobacter pylori infection in early childhood: Independent contributions of infected mothers, fathers and siblings. American Journal of Gastroenterology 2009; 104:182-189.

    138. Widschendter M, Apostolidou S, Raum E, Rothenbacher D, Fiegl H, Menon U, Stegmaier C, Jacobs IJ, Brenner H. Epigenotyping in peripheral blood cell DNA an breast cancer risk: a proof of concept study. PLoS ONE 2008; 3: e2656

    137. Müller H, Haug U, Rothenbacher D, Stegmaier C, Brenner H. Evaluation of serum and urine MRP-14 as marker for early detection of prostate cancer. Journal of Urology 2008; 180: 1309-1312.

    136. Zhang Q, Rothenbacher D. Prevalence of chronic kidney disease in population-based studies: systematic review. BMC Public Health 2008; 8: 117.

    135. von Eynatten M, Hahmann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D. Atherogenic dyslipidemia but not total and high molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. European Heart Journal 2008; 29: 1307-1315.

    134. Raum E, Lietzau S, Stegmaier C, Brenner H, Rothenbacher D. For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany. Pharmacoepidemiology & Drug Safety 2008; 17: 485-494.

    133. Vossen CY, Hoffmann MM,  Hahmann H, Wüsten B, Rothenbacher D, Brenner H. Effect of APOE genotype on lipid levels in patients with coronary heart disease during a 3-week in-patient rehabilitation program. Clinical Pharmacology and Therapeutics 2008; 84:222-227.

    132. Vandenbroucke JP, von Elm  E, Altman DG, al. for the STROBE initiative*. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: Explanation and Elaboration. Ann Intern Med; 2007; 147:W-163-W-194. *Rothenbacher D: member and active contributor

    131. von Elm E, Altman DG, Egger M, et al. for the STROBE initiative*. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement. Guidelines for reporting observational studies. Ann Intern Med 2007; 18: 800-804. *Rothenbacher D: member and active contributor

    130. Haug U, Rothenbacher D, Wente MN, Seiler CM, Stegmaier C, Brenner H. Tumour M2-PK as a stool marker for colorectal cancer: comparative analysis in a large sample of unselected older adults vs colorectal cancer patients. British Journal of Cancer 2007; 96:1329-1334.

    129. Raum E, Rothenbacher D, Ziegler H, Brenner H. Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach. European Journal of Cardiovascular Prevention and Rehabilitation 2007; 14: 809-814.

    128. Weck M N, Stegmaier C, Rothenbacher D, Brenner H. Epidemiology of chronic atrophic gastritis: population based study among 9,444 older adults from Germany. Alimentary Pharmacology &Therapeutics 2007; 26: 879-887.

    127. Arndt V, Rothenbacher D, Zschenderlein B, Schuberth S, Brenner H. Body mass index and premature mortality in physically heavily working men -  a ten year follow-up of 20,000 construction workers. Journal of Occupational and Environmental Medicine 2007; 49: 913-921.

    126. Riera Guardia N, Rothenbacher D. The effect of thiazolidinediones on adiponectin serum level: a meta-analysis. Diabetes, Obesity and Metabolism 2008; 10: 367-375. (Epub 2007).

    125. Weyermann M, Brenner H, Rothenbacher D. Adipokines in human milk and risk of overweight in early childhood: a prospective cohort study. Epidemiology 2007; 18: 722-729.

    124. Brenner H, Rothenbacher D, Weck MN. Epidemiologic findings on serologically defined chronic atrophic gastritis strongly depend on the choice of the cutoff-value. International Journal of Cancer 2007; 121: 2782-2786.

    123. Rothenbacher D, Weyermann M, Fantuzzi G, Brenner H. Adipokines in cord blood and risk of wheezing disorders within the first two years of life. Clinical and Experimental Allergy 2007;  37: 1143-1149.

    122. Haug U, Hillebrand T, Bendzko P, Löw M, Rothenbacher D, Stegmaier C, Brenner H. Mutant-enriched PCR and allele-specific hybridization reaction to detect K-ras mutations in stool DNA: high prevalence in a large sample of older adults. Clinical Chemistry 2007; 53: 787-790.

    121. Zumkeller N, Brenner H, Chang-Claude J, Hoffmeister M; Nieters N, Rothenbacher D. Helicobacter pylori infection, interleukin-1 gene polymorphisms and the risk of colorectal cancer: evidence from a case-control study in Germany. International Journal of Cancer 2007; 43: 1283-1289.

    120. Szabo E, Boehm G, Beermann C, Weyermann M, Brenner H, Rothenbacher D, Decsi T. Trans octadecenoic acid and trans octadecadienoic acid are inversely related to long-chain polyunsaturates in human milk: results of a large birth cohort study. American Journal of Clinical Nutrition 2007; 85: 1320-1326.

    119. Raum E, Rothenbacher D, Ziegler H, Brenner H. Heavy physical activity - risk or protective factor for cardiovascular disease? A life course perspective. Annals of Epidemiology 2007; 17: 417-424.

    118. Rothenbacher D, Hahmann H, Wüsten B, Koenig W, Brenner H. Symptoms of anxiety and depression in patients with stable coronary heart disease: prognostic value and consideration of pathogenetic links. European Journal of Cardiovascular Prevention and Rehabilitation 2007; 14: 547-554.

    117. Wolkewitz M, Rothenbacher D, Löw M, Stegmaier C, Ziegler H, Radulescu M , Brenner H, Diepgen TL. Lifetime prevalence of atopic diseases in a population-based sample of elderly: results of the ESTHER-study. British Journal of Dermatology 2007; 156: 693-697.

    116. The Lp-PLA2 Studies Collaboration: Ballantyne C, Cushman M, Psaty B, Furberg C, Khaw KT, Sandhu M, Oldgren J, Rossi GP, Maiolino G, Cesari M, Lenzini L, James SK, Rimm E, Collins R, Anderson J, Koenig W, Brenner H, Rothenbacher D, Berglund G, Persson M, Berger P, Brilakis E, McConnell JP, Koenig W, Sacco R, Elkind M, Talmud P, Rimm E, Cannon CP, Packard C, Barrett-Connor E, Hofman A, Kardys I, Witteman JC, Criqui M, Corsetti JP, Rainwater DL, Moss AJ, Robins S, Bloomfield H, Collins D, Packard C, Wassertheil-Smoller S, Ridker P, Ballantyne C, Cannon CP, Cushman M, Danesh J, Gu D, Hofman A, Nelson JJ, Thompson S, Zalewski A, Zariffa N, Di Angelantonio E, Kaptoge S, Thompson A, Thompson S, Walker M, Watson S, Wood A. Collaborative meta-analysis of individual participants data from observational studies of Lp-PLA2 and cardiovascular diseases. European Journal of Cardiovascular Prevention and Rehabilitation 2007; 14: 3-11.

    115. Rothenbacher D, Koenig W, Brenner H. Comparison of N-terminal-pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Archives of Internal Medicine 2006; 166: 2455-2460.

    114. Weyermann M, Beermann C, Brenner H, Rothenbacher D. Adiponectin and leptin in maternal serum, cord blood, and human milk. Clinical Chemistry 2006; 52: 2095-2102.

    113. Ongey M, Brenner H, Twardella D, Hahmann H, Rothenbacher D. Role of cytomegalovirus sero-status in the development of secondary cardiovascular events in patients with cardiovascular disease under special consideration of diabetes. International Journal of Cardiology 2006; 111: 98-103.

    112. Weyermann M, Rothenbacher D, Brenner H. Duration of breastfeeding and risk of overweight in childhood: a prospective birth cohort study from Germany. International Journal of Obesity 2006; 30: 1281-1287.

    111. Rothenbacher D, Rüter G, Brenner H. Prognostic value of physicians’ assessment of compliance regarding all-cause mortality in patients with type 2 diabetes: primary care follow-up study. BMC Family Practice 2006; 7: 14.

    110. Brenner H, Weyermann M, Rothenbacher D. Clustering of Helicobacter pylori infection in couples: differences between high and low prevalence population groups. Annals of Epidemiology 2006;16:516-520.

    109. Rothenbacher D, Koenig W, Brenner H. Life time physical activity patterns and risk of coronary heart disease. Heart 2006; 92: 1319-1320.

    108. Koenig W, Twardella D, Brenner H, Rothenbacher D. Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function and hemodynamic stress. Arteriosclerosis, Thrombosis and Vascular Biology 2006; 26: 1586-1593.

    107. Loew M. Hoffmann MM, Hahmann H, März W, Brenner H. Rothenbacher D. Genotype combinations of plasminogen activator inhibitor-1 and angiotensin converting enzyme genes and risk of early onset of coronary heart disease. European Journal of Cardiovascular Prevention and Rehabilitation 2006; 13: 449-456.

    106. Wang H, Rothenbacher D, Löw M, Stegmaier c, Brenner H, Diepgen TL. Atopic diseases, immmunglobulin E and risk of cancer of the prostate, breast, lung and colorectum. International Journal of Cancer 2006; 42: 109-113.

    105. Twardella D, Loew M, Rothenbacher D, Stegmaier C, Ziegler H, Brenner H. The impact of body weight on smoking cessation in German adults. Preventive Medicine 2006; 42: 109-113.

    104. Guech-Ongey M, Brenner H, Twardella D, Rothenbacher D. Chlamydia pneumoniae, heat shock proteins 60 and risk  of secondary cardiovascular events  in patients with coronary heart disease under special consideration of diabetes : a prospective study. BMC cardiovascular disorders 2006 6: 17.

    103. von Eynatten M, Hamann A, Twardella D, Nawroth PP, Brenner H, Rothenbacher D. Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia and heart failure in patients with coronary heart disease. Clinical Chemistry 2006; 52: 853-859.

    102. Weyermann M, Adler G, Brenner H, Rothenbacher D. The mother as intrafamilial source of Helicobacter pylori infection: a prospective birth cohort study. Epidemiology 2006; 17: 332-334.

    101. Spahr A, Klein E, Khuseyinova N, Boeckh C, Muche R, Kunze M, Rothenbacher D, Pezeshki G, Hoffmeister A, Koenig W. Periodontal infections and coronary heart disease: Role of periodontal bacteria and importance of total pathogen burden. The Coronary Event and Periodontal Disease (CORODONT) Study. Archives of Internal Medicine 2006; 166: 554-559.

    100. Zumkeller N, Brenner H, Zwahlen M, Rothenbacher D. Helicobacter pylori infection and colorectal cancer risk: a meta-analysis. Helicobacter 2006; 11: 75-80.

    99. Twardella D, Rothenbacher D, Hahmann H, Wüsten B, Brenner H. The underestimated impact of smoking and smoking cessation on the risk of secondary cardiovascular disease events in patients with stable coronary heart disease: prospective cohort study. The Journal of the American College of Cardiology 2006; 47: 887-889.

    98. Twardella D, Loew M , Rothenbacher  D, Stegmaier C, Ziegler H, Brenner H.  Diagnosis of a smoking-related disease is a prominent trigger for smoking cessation. Journal of Clinical Epidemiology 2006; 59: 82-89.

    97. Rothenbacher D, Müller-Scholze S, Herder C, Koenig W, Kolb H. Differential expression of chemokines, risk of stable coronary heart disease and correlation with established cardiovascular risk markers. Arteriosclerosis, Thrombosis and Vascular Biology 2006; 26: 194-199.

    96. Twardella D, Merx H, Hahmann H, Wüsten B, Rothenbacher D, Brenner H. Long-term adherence to dietary recommendations after in-patient rehabilitation: prospective follow-up study in patients with coronary heart disease. Heart 2006; 92: 635-640.

    95. Rothenbacher D, Brenner H, Rüter G. Betreuung von chronisch Kranken in der Hausarztpraxis am Beispiel des Typ 2 Diabetes. Deutsches Ärzteblatt 2005; 102: A 2408-2412.

    94. Weyermann M, Borowski C, Bode G, Gürbüz B, Adler G, Brenner H, Rothenbacher D. The Helicobacter pylori specific immune response in maternal serum, cord blood, and human milk among mothers with and without current Helicobacter pylori infection. Pediatric Research 2005; 58: 897-902.

    93. Küpper-Nybelen J, Rothenbacher D, Brenner H. Relationship between lifetime alcohol consumption and Helicobacter pylori infection. Annals of Epidemiology 2005; 15: 607-613.

    92. Khuseyinova N, Imhof A, Rothenbacher D, Trischler G, Kuelb S, Scharnagl H, März W, Brenner H, Koenig W. Association between Lp-PLA2 and coronary artery disease: Focus on its relationship with lipoproteins and markers of inflammation and hemostasis. Atherosclerosis 2005; 182: 181-188.

    91. Rothenbacher D, Weyermann M, Beermann C, Brenner H. Breastfeeding, sCD14 concentration in breast milk and risk of atopic dermatitis and asthma in early childhood: birth cohort study. Clinical and Experimental Allergy 2005; 35: 1014-1021.

    90. Arndt V, Rothenbacher D, Daniel D, Zschenderlein B, Schuberth S, Brenner H. Construction work and risk of occupational disability - a 10-year follow-up of 14 474 male workers. Occupational and Environmental Medicine 2005; 62: 559-566.

    89. Brenner H, Rothenbacher D. Helicobacter pylori und Magenkrebs – eine unterschätzte Beziehung. Deutsches Ärzteblatt 2005; 102: A1740-A1743.

    88. Rothenbacher D, Brenner H, Mertens T, Hoffmann MM, Hoffmeister A, Koenig W. Prognostic value of interleukin-1 receptor antagonist gene polymorphism and cytomegalovirus seroprevalence in patients with coronary artery disease. BMC Cardiovascular Disorders 2005, 5:10.

    87. Loew M, Hoffmann MM, Hahmann H, März W, Rothenbacher D, Brenner H. Smoking, apolipoprotein E genotype, and early onset of coronary heart disease. European Journal of Cardiovascular Prevention and Rehabilitation 2005; 12: 268-270.

    86. Rothenbacher D, Brenner H, März W, Koenig W. Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. European Heart Journal 2005; 26:1640-1646.

    85. Loew M, Hoffmann MM, Koenig W, Brenner H, Rothenbacher D. Genotype and plasma concentration of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events.  Arteriosclerosis, Thrombosis and Vascular Biology 2005; 25: 1470-1474.

    84. Rothenbacher D, Löw M, Hardt PD, Klör HU, Ziegler H, Brenner H. Prevalence and determinants of exocrine pancreatic insufficiency among older adults: results of a population based study. Scandinavian Journal of Gastroenterology 2005; 40: 697-704.

    83. Zumkeller N, Koenig W, Hoffmann  MM, Kolb  H, Brenner H, Rothenbacher D. Helicobacter pylori seropositive subjects do not show a pronounced systemic inflammatory response even in the presence of the interleukin-1 receptor antagonist gene polymorphism. Epidemiology and Infection 2005; 133: 569-572.

    82. Hoffmeister A, Rothenbacher D, Kunze M, Brenner H, Koenig W. Prognostic value of inflammatory markers alone and in combination with blood lipids in patients with stable coronary artery disease. European Journal of Internal Medicine 2005;16:47-52.

    81. Weyermann M, Rothenbacher D, Gayer L, Bode G, Adler G, Grab D, Flock F, Brenner H. Helicobacter pylori infection and iron deficiency during pregnancy. American Journal of Obstetrics and Gynecology 2005; 192: 548-553.

    80. Koenig W, Twardella D, Brenner H, Rothenbacher D. Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: More than simply a marker of glomerular filtration rate. Clinical Chemistry 2005; 51:321-327.

    79. Küpper-Nybelen J, Thefeld W, Rothenbacher D, Brenner H. Patterns of alcohol consumption and Helicobacter pylori infection: Results of a population based study from Germany among 6545 adults. Alimentary Pharmacology & Therapeutics 2005; 21: 57-64.

    78. Ongey, M, Brenner H, Thefeld W, Rothenbacher D. Helicobacter pylori and Hepatitis A virus infections and the cardiovascular risk profile in patients with diabetes mellitus: Results of a population based study. European Journal of Cardiovascular Prevention and Rehabilitation 2004; 11: 471-476.

    77. Löw M, Stegmaier C, Ziegler H, Rothenbacher D, Brenner H. Epidemiologische Studie zu Chancen der Verhütung, Früherkennung und optimierten Therapie chronischer Erkrankungen in der älteren Bevölkerung (ESTHER-Studie). Deutsche Medizinische Wochenschrift 2004; 129: 2643-2647.

    76. Twardella D, Küpper-Nybelen J, Rothenbacher D, Hahmann H, Wüsten B, Brenner H. Short-term benefit of smoking cessation in patients with coronary heart disease: estimates based on self-reported smoking data and serum cotinine measurements. European Heart Journal 2004; 25: 2101-2108.

    75. Arndt V, Rothenbacher D, Krauledat R, Daniel U, Brenner H. Age, alcohol consumption and all cause mortality. Annals of Epidemiology 2004;14: 750-753.

    74. Perez-Perez GI, Rothenbacher D, Brenner H. Epidemiology of Helicobacter pylori infection. Helicobacter. 2004;9 Suppl 1:1-6.

    73. Rothenbacher D, Weyermann M, Bode G, Kulaksiz M, Stahl B, Brenner H. Role of Lewis A and Lewis B blood group antigens in Helicobacter pylori infection. Helicobacter 2004; 9: 324-329.

    72. Bergk V, Gasse C, Rothenbacher D, Loew M, Brenner H, Haefeli WE. Drug interactions in primary care: impact of a new algorithm on risk determination. Clinical Pharmacology and Therapeutics 2004; 76: 85-96.

    71. Rothenbacher D, Schultze V, Jähnig P, Scharschmidt B, Brenner H. Evidence of a rapid decrease in prevalence of H pylori infection in children of a high risk group living in Germany. European Journal of Pediatrics 2004; 163: 339-340.

    70. März W, Nauck M, Hofmann MM, Nagel D, Boehm BO, Koenig W, Rothenbacher D, Winkelmann BR. The G(-30)A polymorphism in the pancreatic promoter of the glukokinase gene is associated with angiographic coronary artery disease, type 2 diabetes mellitus and glucose metabolism. Circulation 2004; 109: 2844- 2849.

    69. Arndt V, Rothenbacher D, Daniel U, Zschenderlein B, Schuberth S, Brenner H. All-cause and cause specific mortality in a cohort of 20000 construction workers. Results from a 10 year-follow-up. Occupational and Environmental Medicine 2004; 61: 419-425.

    68. Brenner H, Arndt V, Stegmaier C, Ziegler H, Rothenbacher D. Is Helicobacter pylori infection a necessary condition for non-cardia gastric cancer? American Journal of Epidemiology 2004; 159: 252-258.

    67. Küpper-Nybelen J, Rothenbacher D, Jacobi E, Brenner H. Die prognostische Bedeutung von Variablen aus dem Qualitätssicherungsprogramm und  dem Reha-Entlassungsbericht der LVA-Württemberg für die Erwerbs- oder Berufsunfähigkeit: Ergebnisse einer retrospektiven Kohortenstudie. Die Rehabilitation. 2003; 42: 335-342.

    66. Imhof A, Rothenbacher D, Khuseyinova N, Hoffmeister A, Maerz W, Nauck M, Scharnagl H, Koenig W, Brenner H. Plasma lipoprotein Lp(a) and risk of coronary heart disease: what are the mechanisms involved? Journal of Cardiovascular Risk 2003; 10: 362-370.

    65. Rothenbacher D, Brenner H, Hoffmeister A, Mertens T, Persson K, Koenig W Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group. Atherosclerosis 2003; 170: 339-345.

    64. Hoffmeister A, Imhof A, Rothenbacher D, Khuseyinova N, Brenner H, Koenig W. Moderater Alkoholkonsum und Plasmakonzentration sensitiver Entzündungsmarker– Hinweise auf einen atheroprotektiven Zusammenhang. Deutsche Medizinische Wochenschrift 2003; 128: 2237-2241.

    63. Weyermann W, Brenner H, Adler G, Yasar Z, Handke-Vesely A, Grab D, Kreienberg R, Rothenbacher D. Helicobacter pylori infection and occurrence and severity of gastrointestinal symptoms during pregnancy. American Journal of Obstetrics and Gynecology 2003; 189: 526-531.

    62. Khuseyinova N, Imhof A, Trischler G, Rothenbacher D, Hutchinson WL, Pepys MB, Koenig W. Determination of C-reactive protein: comparison of three high sensitivity immunoassays. Clinical Chemistry 2003; 49: 1691-1695.

    61. Küpper-Nybelen J, Rothenbacher D, Hahmann H, Wüsten B, Brenner H. Veränderungen von Risikofaktoren während und ein Jahr nach stationärer Rehabilitation bei Patienten mit koronarer Herzkrankheit. Deutsche Medizinische Wochenschrift 2003; 128: 1525-1530.

    60. Rothenbacher D, Brenner H. Burden of Helicobacter pylori and H. pylori related diseases in developed countries: recent developments and future implications. Microbes and Infection 2003; 5: 693-703.

    59. Rothenbacher D, Hoffmeister A, Brenner H, Koenig W. Physical activity, coronary heart disease and inflammatory response. Archives of Internal Medicine 2003; 163: 1200-1205.

    58. Rothenbacher D, Rüter G, Saam S, Brenner H. Younger patients with type 2 diabetes need better glycaemic control: results of a community-based study describing factors associated with a high HbA1c-value. British Journal of General Practice 2003; 53: 389-391.

    57. Bode, G, Brenner H, Adler G, Rothenbacher D. Recurrent abdominal pain in children: Evidence from a population based study that social and familial factors play a role but not Helicobacter pylori. Journal of Psychosomatic Research 2003; 54: 417-421.

    56. Hoffmeister A, Rothenbacher D, Khuseyinova N, Brenner H, Koenig W. Plasminogen levels are not associated with risk of coronary artery disease. The American Journal of Cardiology 2002; 90: 1168-1170.

    55. Bode G, Piechotowski I, Rothenbacher D, Brenner H. The Helicobacter pylori specific immune response of children: Implications for future vaccination strategy? Clinical & Diagnostic Laboratory Immunology 2002; 9: 1126-1128.

    54. Rothenbacher D, Bode G, Brenner H. Dynamics of Helicobacter pylori infection in early childhood in a high risk group living in Germany: loss of infection higher than acquisition. Alimentary Pharmacology & Therapeutics 2002; 16: 1663-1668.

    53. Rothenbacher D, Winkler M, Gonser T, Adler G, Brenner H. Role of infected parents in transmission of Helicobacter pylori to their children. The Pediatric Infectious Disease Journal 2002; 21: 674-679.

    52. Koenig W, MD, Khuseyinova N, Hoffmann MM, März W, Fröhlich M, Hoffmeister A, Brenner H, Rothenbacher D. CD14 C(-260 )T polymorphism, plasma levels of the soluble endotoxin receptor CD14, their association with chronic infections, and risk of stable coronary artery disease. Journal of the American College of Cardiology 2002; 40: 34-42.

    51. Bode G, Brenner H, Adler G, Rothenbacher D. Dyspeptic symptoms in middle-aged to old adults: The role of Helicobacter pylori-infection, and various demographic and lifestyle factors. Journal of Internal Medicine 2002; 252: 41-47.

    50. Rothenbacher D, Bode G, Brenner H. History of breastfeeding and Helicobacter pylori infection in pre-school children: results of a population based study from Germany. International Journal of Epidemiology 2002; 31: 632-637.

    49. Rothenbacher D, Rüter G, Saam S, Brenner H. Versorgung von Patienten mit Typ-2-Diabetes: Ergebnisse aus 12 Hausarztpraxen. Deutsche Medizinische Wochenschrift 2002; 127: 1183-1187.

    48. Rothenbacher D, Fischer HG, Hoffmeister A, Hoffmann MM, März W, Bode G, Rosenthal J, Koenig W, Brenner H. Homocysteine and methylenetetrahydrofolate reductase genotype: association with risk of coronary heart disease and relation to inflammatory, hemostatic, and lipid parameters. Atherosclerosis 2002; 162: 193-200.

    47. Bode G, Marchildon P, Peacock J, Brenner H, Rothenbacher D. Diagnosis of Helicobacter pylori infection in children aged 5 to 7 years: Comparison of a salivary IgG antibody test with 13C-urea breath test. Clinical and Diagnostic Laboratory Immunology 2002; 9: 493-495.

    46. Bode G, Rothenbacher D, Brenner H. Helicobacter pylori colonization and diarrhoeal illness: Results of a population-based cross-sectional study in adults. The European Journal of Epidemiology 2001; 17: 823-827.

    45. Bode G, Hoffmeister A, Koenig W, Brenner H, Rothenbacher D. Characteristics of differences in Helicobacter pylori serology and 13C-urea breath testing in an asymptomatic sample of blood donors. The Scandinavian Journal of Clinical & Laboratory Investigation 2001; 61: 603-608.

    44. Siebert U, Rothenbacher D, Daniel U, Brenner H. Demonstration of the healthy worker survivor effect in a cohort of workers in the construction industry. Occupational and Environmental Medicine. 2001; 58: 774-779.

    43. Koenig W, Rothenbacher D, Hoffmeister A, Bäzner U, Griesshammer M, Brenner H. Plasma fibrin D-Dimer levels and risk of stable coronary artery Disease: results of a large case-control study. Arteriosclerosis, Thrombosis, and Vascular Biology. 2001; 21: 1701-1705.

    42. Brenner H, Rothenbacher D, Bode G, März W, Hoffmeister A, Koenig W. Coronary heart disease risk reduction in a predominantly beer-drinking population. Epidemiology 2001; 12: 390-395.

    41. Rothenbacher D, Bode G, Gonser T, Adler G, Brenner H. Helicobacter pylori-Infektion bei Kindern. Deutsches Ärzteblatt 2001; 98: A986-989.

    40. Rothenbacher D, Hoffmeister A, Bode G, Miller M, Koenig W, Brenner H. Helicobacter pylori heat shock protein 60 and risk of coronary heart disease: a case-control study with focus on markers of systemic inflammation and lipids. Atherosclerosis 2001; 156: 193-199.

    39. Brenner H, Bode G, Adler G, Hoffmeister A, Koenig W, Rothenbacher D. Alcohol as a gastric disinfectant? The complex relation between alcohol consumption and current Helicobacter pylori infection. Epidemiology 2001; 12: 209-214.

    38. Hoffmeister A, Rothenbacher D, Bäzner U, Fröhlich M, Brenner H, Hombach V, Koenig W. Role of novel markers of inflammation in patients with stable coronary heart disease. American Journal of Cardiology 2001; 87: 262-266.

    37. Hoffmeister A, Rothenbacher D, Bode G, Persson K, März W, Nauck MA, Brenner H, Hombach V, Koenig W. Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile. Arteriosclerosis, Thrombosis and Vascular Biology 2001; 21: 427-432.

    36. Rothenbacher D, Blaser MJ, Bode G, Brenner H. An inverse relationship between gastric colonization of Helicobacter pylori and diarrheal illnesses in children: results of a population-based cross-sectional study. Journal of Infectious Diseases 2000; 182: 1446-9.

    35. Bode G, Brenner H, Adler G, Rothenbacher D. Helicobacter pylori infection, intake of analgesics or anti-inflammatory medication and personal factors in relation to dyspeptic symptoms in patients of a general practitioner. British Journal of General Practice 2000; 50: 615-9.

    34. Rothenbacher D, Inceoglu J, Bode G, Brenner H. Acquisition of Helicobacter pylori infection in a high risk population occurs within the first two years of life. Journal of Pediatrics 2000; 136: 744-8.

    33. Rothenbacher D, Bode G, Brenner H. Diagnosis of Helicobacter pylori infection with a novel stool antigen-based assay in children. Pediatric Infectious Disease Journal 2000; 19: 364-346.

    32. Brenner H, Bode G, Adler G, Rothenbacher D. Does maternal smoking hinder mother-child transmission of Helicobacter pylori? Epidemiology 2000; 11: 71-75.

    31. Hoffmeister A, Rothenbacher D, Wanner P, Bode G, Persson K, Brenner H, Hombach V, Koenig W. Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease - negative results of a case control study.  Journal of the American College of Cardiology 2000; 35: 112-118.

    30. Koenig W, Rothenbacher D, Hoffmeister A, Miller M, Bode G, Adler G, Hombach V, März W, Pepys MB, Brenner H. Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: Lack of a role of CagA-positive strains and absence of a systemic inflammatory response. Circulation 1999; 100: 2326-2331.

    29. Rothenbacher D, Hoffmeister A, Bode G, Wanner P, Koenig W, Brenner H. Cytomegalovirus infection and coronary heart disease: results of a case-control study from Germany. Journal of Infectious Diseases 1999; 179: 690-692.

    28. Rothenbacher D, Bode G, Berg G, Knayer U, Gonser T, Adler G, Brenner H. Helicobacter pylori among pre-school children and their parents: evidence for parent-child transmission. Journal of Infectious Diseases 1999; 179: 398-402.

    27. Brenner H, Rothenbacher D, Bode G, Dieudonné P. Adler G. Active infection with Helicobacter pylori in healthy couples. Epidemiology and Infection 1999; 122: 91-95.

    26. Gonser T, Rothenbacher D, Bode G, Adler G, Brenner H. Möglichkeiten epidemiologischer Erhebungen im Rahmen von  Einschulungsuntersuchungen am Beispiel der Ulmer Helicobacter pylori Studien. Das Gesundheitswesen 1999; 60: S24-S29.

    25. Brenner H, Rothenbacher D, Bode G, Adler G. Inverse graded alcohol consumption and active infection with Helicobacter pylori. American Journal of Epidemiology 1999; 149: 571-576.

    24. Rothenbacher D, Peter R, Bode G, Adler G, Brenner H. Dyspepsia in relation to Helicobacter pylori infection and psychosocial work stress in white collar employees.  American Journal of Gastroenterology 1998; 93: 1443-1449.

    23. Bode G, Rothenbacher D, Brenner H, Adler G. Variation of the 13C-urea breath test value by nationality in H pylori infected children. Scandinavian Journal of Gastroenterology 1998; 33: 468-472.

    22. Arndt V, Brenner H, Rothenbacher D, Zschenderlein B, Fraisse E, Fliedner TM. Elevated liver enzyme activity in construction workers: prevalence and impact on early retirement and all-cause mortality. International Archives of Occupational and Environmental Health 1998; 71: 405-412.

    21. Rothenbacher D, Bode G, Peschke F, Berg G, Adler G, Brenner H. Active infection with Helicobacter pylori in an asymptomatic population of middle aged to elderly. Epidemiology and Infection 1998; 120: 297-303.

    20. Brenner H, Rothenbacher D, Bode G, Adler G. The individual and joint contributions to Helicobacter pylori infection and family history to the risk for peptic ulcer disease. Journal of Infectious Diseases 1998; 177: 1124-1127.

    19. Brenner H, Rothenbacher D, Bode G, Gommel R, Berg G,  Adler G. Parental smoking and infection with Helicobacter pylori among pre-school children in Southern Germany. Epidemiology 1998; 9: 545-549.

    18. Bode G, Rothenbacher D, Brenner H, Adler G. Pets are no risk factor for H. pylori infection in young children. Results of a population based study in Southern Germany.  Pediatric Infectious Disease Journal 1998; 17: 909-912.

    17. Bode G, Rothenbacher D, Brenner H, Adler G.  Helicobacter pylori and abdominal symptoms: a population based study among pre-school children in Southern Germany. Pediatrics 1998;101:634 637.

    16. Brenner H, Rothenbacher D, Bode G, Adler G. Parental history of gastric or duodenal ulcer and Helicobacter pylori infection among pre-school children: evidence for mother-infant transmission. British Medical Journal 1998; 316: 665 (Originalarbeit).

    15. Rothenbacher D, Bode G, Adler G, Brenner H. History of antibiotic treatment and prevalence of H. pylori infection among children: results of a population based study.  Journal of Clinical Epidemiology 1998; 51: 267-271.

    14. Rothenbacher D, Bode G, Berg G, Gommel R, Gonser T, Adler G, Brenner H. Prevalence and determinants of H. pylori infection in preschool children - a population based epidemiological study from Germany. International Journal of Epidemiology 1998; 27: 135-141.

    13. Rothenbacher D, Arndt V, Fraisse E, Zschenderlein B, Fliedner TM, Brenner H. Early retirement due to permanent disability in relation to smoking in workers of the construction industry. Journal of Occupational and Environmental Medicine 1998; 40: 63-68.

    12. Brenner H, Arndt V, Rothenbacher D, Schuberth S, Fraisse E, Fliedner TM. Body weight, pre-existing disease and all-cause mortality in a cohort of male employees in the German construction industry. Journal of Clinical Epidemiology 1997; 50: 1099-1106.

    11. Brenner H, Rothenbacher D, Bode G, Adler G. Relation of smoking, alcohol and coffee consumption to active infection with Helicobacter pylori. British Medical Journal 1997; 315: 1489-1492.

    10. Rothenbacher D, Bode G, Adler G, Brenner H. Use of commonly prescribed antibiotics is not associated with prevalence of Helicobacter pylori infection in adults. Scandinavian Journal of Gastroenterology 1997; 32: 1096-1099.

    9. Rothenbacher D, Bode G, Winz T, Berg G, Adler G, Brenner H. H. pylori in out-patients of a general practitioner: Prevalence and determinants for current infection. Epidemiology and Infection 1997; 119: 151-157.

    8. Rothenbacher D, Lutz MP, Porzsolt F. Treatment decisions in palliative cancer care: Patients' preferences for involvement and doctors' knowledge about it. European Journal of Cancer 1997; 33: 1184-89.

    7. Brenner H, Rothenbacher D, Arndt V, Schuberth S, Fraisse E, Fliedner TM. Distribution, determinants and prognostic value of γ-glutamyltransferase for all-cause mortality in a cohort of construction workers from southern Germany. Preventive Medicine 1997; 26: 305-310.

    6. Rothenbacher D, Arndt V, Fraisse E, Daniel U, Fliedner TM, Brenner H. Chronic respiratory disease morbidity in construction workers: patterns and prognostic significance for permanent disability and overall mortality. European Respiratory Journal 1997; 10: 1093-1099.

    5. Brenner H, Arndt V, Rothenbacher D, Schuberth S, Fraisse E, Fliedner TM. The association between alcohol consumption and all-cause mortality in a cohort of male employees in the German construction industry. International Journal of Epidemiology 1997; 26: 85-91.

    4. Rothenbacher D, Brenner H, Arndt V, Fraisse E, Zschenderlein B, Fliedner TM. Disorders of the back and spine in construction workers: prevalence and prognostic value for disability. Spine 1997; 22: 1481-1486.

    3. Arndt V, Rothenbacher D, Brenner H, Fraisse E, Zschenderlein B, Daniel U, Schuberth S, Fliedner TM. Older workers in the construction industry - results of a routine health examination and a five year follow-up. Occupational and Environmental Medicine 1996; 53: 686-691.

    2. Rothenbacher D, Brenner H, Arndt V, Fraisse E, Zschenderlein B, Fliedner TM. Smoking patterns and mortality attributable to smoking in a cohort of 3528 construction workers. European Journal of Epidemiology 1996; 12: 335-340.

    1. Shy C, Degnan D, Fox D L, Mukerjee S, Hazucha M J, Boehlecke B A, Rothenbacher D, Briggs P M, Delvin R B, Wallace D D, Stevens R K, Bromberg P A: Do waste incinerators induce adverse respiratory effects? An air quality and epidemiological study of six communities. Environmental Health Perspectives 1995; 103: 714-724.
  • Beruflicher Werdegang

    Beruflicher Werdegang

    Prof. Dr. med. Dietrich Rothenbacher leitet seit Dezember 2010 das Institut für Epidemiologie und Medizinische Biometrie an der Medizinischen Fakultät Ulm der Universität Ulm. Nach dem Studium der Medizin an der Universität Ulm arbeitete er von 1989-1991 am Institut für Arbeits- und Sozialmedizin der Universität Ulm. An der “School of Public Health at the University of North Carolina in Chapel Hill (USA)” absolvierte er dann einen Master of Public Health (MPH) im Fach Epidemiology.  Nach einer klinischen Weiterbildungszeit auf der Inneren Medizin Anerkennung als Arzt für Arbeitsmedizin. Danach war er als Wissenschaftlicher Mitarbeiter am Aufbau des neu-gegründeten Institut für Epidemiologie der Universität Ulm beteiligt. Weitere Stationen führten ins Deutsche Zentrum für Alternsforschung (2000-2005) und ans Deutsche Krebsforschungszentrum (2006), beide in Heidelberg. Von 2007-2010 war er bei der Novartis Pharma AG in Basel in der Abteilung „Drug Safety and Epidemiology“ tätig.

Leiter des Instituts für Epidemiologie und Med. Biometrie